Ann: Zantrene AML trial in Israel advances to Phase 2, page-143

I asked about the distribution of numbers on the investor hub, as I was also thinking 22 was 1 shy of full recruitment and completion of both phase 1 and 2. (going by my understanding of details in original announcements).

Response received indicates there was as expansion stage to phase 1 (separate to Phase 2), which in original announcement does say up to 12 patients. So from response, numbers provided where 13 in phase 1 ( 6 dose escalation 7 in expansion), then 7 recruited for the stage 1 of the phase 2, for total of 22 patients.